WO2006076255A3 - Method of treating or preventing microbial eye infection - Google Patents

Method of treating or preventing microbial eye infection Download PDF

Info

Publication number
WO2006076255A3
WO2006076255A3 PCT/US2006/000593 US2006000593W WO2006076255A3 WO 2006076255 A3 WO2006076255 A3 WO 2006076255A3 US 2006000593 W US2006000593 W US 2006000593W WO 2006076255 A3 WO2006076255 A3 WO 2006076255A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
infection
eye infection
preventing microbial
eye
Prior art date
Application number
PCT/US2006/000593
Other languages
French (fr)
Other versions
WO2006076255A2 (en
Inventor
Ling Chi Huang
Allan L Goldstein
David Crockford
Jack Finkelstein Jr
Original Assignee
Regenerx Biopharmaceuticals
Ling Chi Huang
Allan L Goldstein
David Crockford
Jack Finkelstein Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenerx Biopharmaceuticals, Ling Chi Huang, Allan L Goldstein, David Crockford, Jack Finkelstein Jr filed Critical Regenerx Biopharmaceuticals
Publication of WO2006076255A2 publication Critical patent/WO2006076255A2/en
Publication of WO2006076255A3 publication Critical patent/WO2006076255A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method of treatment for treating, preventing, inhibiting or reducing microbial eye infection of eye tissue of a subject, includes administering to a subject in need of such treatment an effective amount of a composition including an antimicrobial agent including amino acid sequence LKKTET or LKKTNT, a conservative variant thereof, or an agent that stimulates production of an LKKTET or LKKTNT peptide, or a conservative variant thereof, in the tissue, so as to inhibit the infection.
PCT/US2006/000593 2005-01-11 2006-01-10 Method of treating or preventing microbial eye infection WO2006076255A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64252005P 2005-01-11 2005-01-11
US64251605P 2005-01-11 2005-01-11
US60/642,516 2005-01-11
US60/642,520 2005-01-11

Publications (2)

Publication Number Publication Date
WO2006076255A2 WO2006076255A2 (en) 2006-07-20
WO2006076255A3 true WO2006076255A3 (en) 2007-12-13

Family

ID=36678103

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/000593 WO2006076255A2 (en) 2005-01-11 2006-01-10 Method of treating or preventing microbial eye infection

Country Status (1)

Country Link
WO (1) WO2006076255A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011279539A1 (en) * 2010-07-14 2013-03-07 Adistem Ltd Method of treatment of HIV or AIDS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040617A9 (en) * 1999-03-12 2003-02-27 Rosen Craig A. Nucleic acids, proteins and antibodies
US20040131626A1 (en) * 2001-03-15 2004-07-08 Goldstein Allan L. Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040617A9 (en) * 1999-03-12 2003-02-27 Rosen Craig A. Nucleic acids, proteins and antibodies
US20040131626A1 (en) * 2001-03-15 2004-07-08 Goldstein Allan L. Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives

Also Published As

Publication number Publication date
WO2006076255A2 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
EP1880719A3 (en) Composition for prophylaxis or treatment of urinary system infection and method thereof
BRPI0514420A (en) peptide, variant thereof, or a pharmaceutically acceptable salt thereof, composition, use of a peptide or peptide variant, substrate, and methods of treating or preventing a microbial infection, and treating a wound in an individual
NZ701559A (en) Compositions comprising povidone-iodine
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
EA200802166A1 (en) STABLE PHARMACEUTICAL COMPOSITION WITH PROTECTIVE ACTION AGAINST IRRITATION (OPTIONS), METHOD FOR ITS PREPARATION AND METHOD OF TREATING CALCIUM MIMETIC WITH IT WITH HELP
WO2009129437A3 (en) Methods and compositions for treating post-operative pain comprising clonidine
EP1945234A4 (en) Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients
WO2009027820A3 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
WO2007112000A3 (en) Treatment of pain
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
WO2008089268A3 (en) Methods and compositions for treating conditions associated with infection and/or inflammation
BRPI1007379B8 (en) pharmaceutical compositions for the treatment or prevention of oral infections by e. coli
WO2009111064A3 (en) Minocycline compounds and methods of use thereof
WO2007014253A3 (en) Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
WO2010030180A3 (en) Peptide formulations and uses thereof
TW200639159A (en) Treatment of pain
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2006135493A3 (en) A composition for wound healing and use thereof
RU2012157473A (en) METHOD FOR IDENTIFICATION OR TREATMENT OF REACTION "TRANSPLANT AGAINST THE OWNER"
HK1114876A1 (en) Arthrospira-based compositions and uses thereof
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
EP2889034A3 (en) Compositions and methods of treatment comprising ceftaroline
EP3939599A3 (en) Silicate containing compositions and methods of treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06717756

Country of ref document: EP

Kind code of ref document: A2